- Comparison of total plasma lysophosphatidic acid and serum CA-125 as a tumor marker in the diagnosis and follow-up of patients with epithelial ovarian cancer
-
Bese T, Barbaros M, Baykara E, Guralp O, Cengiz S, Demirkiran F, Sanioglu C, Arvas M
- KMID: 2173549
- J Gynecol Oncol.
- 2010 Dec;21(4):248-254.
- doi: 10.3802/jgo.2010.21.4.248
OBJECTIVE: To evaluate the role of lysophosphatidic acid (LPA) as a tumor marker in diagnosis and follow-up of patients with epithelial ovarian cancer. METHODS: Eighty-seven epithelial ovarian cancer patients, 74 benign... -
- CITED
-
- Close
- SHARE
-
- Close
- Serum Neurofilament Light Chain Levels Are Related to Small Vessel Disease Burden
-
Duering M, Konieczny , Tiedt S, Baykara E, Tuladhar A, van Leijsen E, Lyrer P, Engelter S, Gesierich , Achmüller M, Barro C, Adam R, Ewers M, Dichgans M, Kuhle J, de Leeuw F, Peters N
- KMID: 2424426
- J Stroke.
- 2018 May;20(2):228-238.
- doi: 10.5853/jos.2017.02565
BACKGROUND AND PURPOSE: Neurofilament light chain (NfL) is a blood marker for neuroaxonal damage. We assessed the association between serum NfL and cerebral small vessel disease (SVD), which is highly... -
- CITED
-
- Close
- SHARE
-
- Close
